London,: The second edition of the London Biotechnology Show (#LBS) continues to elevate its prestige with each passing day, as more renowned speakers and leading exhibitors join the lineup, solidifying its position as a premier platform for addressing the biotech sector's most critical challenges and groundbreaking opportunities.
The conference agenda is packed with thought-provoking keynote speeches, interactive discussions, and panel sessions. Attendees will gain insights into groundbreaking topics such as gene editing, regenerative medicine, pharmaceuticals, bioinformatics, medical devices , biomedical engineering, biotechnology in agriculture, and the latest in digital health. This year’s program not only delves into emerging trends but also provides actionable strategies for professionals shaping the future of biotechnology.
Ready to deliver on these crucial topics, the conference features an exceptional lineup, including representatives from leading organizations such as Google, Novo Nordisk, Microsoft, Bayer Pharmaceuticals, the Medicines and Healthcare products Regulatory Agency, Genomics England, and AstraZeneca. Notable participants include:
● Andrew Miles - Multicultural Executive & Leader in Life Sciences and Technology - Google
● Dr. Bryn Roberts - Global Head of Data, Analytics & Research - Roche Information Solutions
● Thomas Balkizas - Senior Director Life Sciences - Microsoft
● Dr. Nicole Mather - Health & Life Sciences Leader - IBM
● Professor Sir Mark Caulfield - Vice Principal for Health, Faculty of Medicine and Dentistry - Queen Mary University of London
● Sadegh Mohammadi - Head of Computer Vision and Sound Analysis - Bayer Pharmaceuticals
● Mark Davies - Chief Health Officer - IBM
